Literature DB >> 17588138

Extracellular heat shock protein 60 (Hsp60) levels in children with septic shock.

D S Wheeler1, P Lahni, K Odoms, B R Jacobs, J A Carcillo, L A Doughty, H R Wong.   

Abstract

OBJECTIVE AND
DESIGN: Recent data suggest that extracellular Hsp60 modulates the host innate immune response. We analyzed plasma Hsp60 levels in children admitted to a level III tertiary care PICU with septic shock. MATERIALS AND
SUBJECTS: Blood samples were obtained from children meeting criteria for septic shock (n = 63), critically ill children without septic shock (n = 10), and healthy controls (n = 24). TREATMENT: Not applicable.
METHODS: Hsp60 levels were measured in the plasma using a commercially available ELISA. Differences between groups were analyzed with a Kruskal-Wallis one way ANOVA due to the non-parametric nature of the data. A p value < or = 0.05 was considered significant.
RESULTS: Extracellular Hsp60 levels were significantly higher in children with septic shock (median, 16.7 ng/mL) compared to both critically ill children without septic shock (median, 0 ng/mL) and healthy controls (median, 0 ng/mL, p <0.001).
CONCLUSIONS: Extracellular Hsp60 levels are significantly elevated in children with septic shock compared with both healthy controls and critically ill children without sepsis. Extracellular Hsp60 may play a role in the pathogenesis of sepsis in children.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17588138     DOI: 10.1007/s00011-007-6108-4

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  12 in total

Review 1.  Biomarker discovery and development in pediatric critical care medicine.

Authors:  Jennifer M Kaplan; Hector R Wong
Journal:  Pediatr Crit Care Med       Date:  2011-03       Impact factor: 3.624

2.  Pediatric Sepsis - Part V: Extracellular Heat Shock Proteins: Alarmins for the Host Immune System.

Authors:  John S Giuliano; Patrick M Lahni; Hector R Wong; Derek S Wheeler
Journal:  Open Inflamm J       Date:  2011-10-07

Review 3.  Pathophysiology of Pediatric Multiple Organ Dysfunction Syndrome.

Authors:  Joseph A Carcillo; Bradley Podd; Rajesh Aneja; Scott L Weiss; Mark W Hall; Timothy T Cornell; Thomas P Shanley; Lesley A Doughty; Trung C Nguyen
Journal:  Pediatr Crit Care Med       Date:  2017-03       Impact factor: 3.624

Review 4.  Pathophysiology and treatment of septic shock in neonates.

Authors:  James L Wynn; Hector R Wong
Journal:  Clin Perinatol       Date:  2010-06       Impact factor: 3.430

Review 5.  Microbial recognition and danger signals in sepsis and trauma.

Authors:  Steven L Raymond; David C Holden; Juan C Mira; Julie A Stortz; Tyler J Loftus; Alicia M Mohr; Lyle L Moldawer; Frederick A Moore; Shawn D Larson; Philip A Efron
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-01-20       Impact factor: 5.187

Review 6.  Role of Mitochondria-Derived Danger Signals Released After Injury in Systemic Inflammation and Sepsis.

Authors:  Kiyoshi Itagaki; Ingred Riça; Barbora Konecna; Hyo In Kim; Jinbong Park; Elzbieta Kaczmarek; Carl J Hauser
Journal:  Antioxid Redox Signal       Date:  2021-05-25       Impact factor: 7.468

7.  Alarmin function of galectin-9 in murine respiratory tularemia.

Authors:  Anthony L Steichen; Tanner J Simonson; Sharon L Salmon; Dennis W Metzger; Bibhuti B Mishra; Jyotika Sharma
Journal:  PLoS One       Date:  2015-04-21       Impact factor: 3.240

Review 8.  Damage-associated molecular patterns in trauma.

Authors:  Borna Relja; Walter Gottlieb Land
Journal:  Eur J Trauma Emerg Surg       Date:  2019-10-14       Impact factor: 3.693

9.  Galectin-3 functions as an alarmin: pathogenic role for sepsis development in murine respiratory tularemia.

Authors:  Bibhuti B Mishra; Qun Li; Anthony L Steichen; Brandilyn J Binstock; Dennis W Metzger; Judy M Teale; Jyotika Sharma
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

Review 10.  Danger signals in trauma.

Authors:  Borna Relja; Katharina Mörs; Ingo Marzi
Journal:  Eur J Trauma Emerg Surg       Date:  2018-05-04       Impact factor: 3.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.